Overview
I see patients with chronic liver diseases. I have a clinical and research interest in nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). Areas of interest include identifying patients at high risk for NAFLD/NASH, developing care pathways to specialty care and creating sustainable multidisciplinary and lifestyle programs for people impacted with NAFLD/NASH.
Current Appointments & Affiliations
Associate Professor of Medicine
·
2023 - Present
Medicine, Gastroenterology,
Medicine
Recent Publications
The Basics of Metabolic Dysfunction-Associated Steatotic Liver Disease for Cardiologists: Pathophysiology, Diagnosis, and Treatment.
Journal Article J Am Coll Cardiol · November 18, 2025 Metabolic dysfunction-associated steatotic liver disease (MASLD) is now recognized as a multisystem disease closely linked to cardiovascular disease, which is the leading cause of death in this population. MASLD and cardiovascular disease share overlapping ... Full text Link to item CiteS2394 Metabolic Dysfunction-Associated Steatotic Liver Disease and Hormone Therapy for Gender-Affirming Care
Conference American Journal of Gastroenterology · October 2025 Full text CiteChange in cT1 Following Interventions in MASLD: A Systematic Review and Meta-Analysis.
Journal Article Clin Gastroenterol Hepatol · April 10, 2025 BACKGROUND AND AIMS: Liver corrected T1 (cT1), measured with multiparametric magnetic resonance imaging, offers an alternative to liver biopsy to monitor treatment response and liver disease activity. We aimed to perform a systematic evaluation of change i ... Full text Link to item CiteRecent Grants
BIO89-100-132 The ENLIGHTEN-Cirrhosis Pro00116849
Clinical TrialPrincipal Investigator · Awarded by 89bio, Inc · 2024 - 2031BIO89-100-131 The ENLIGHTEN-Fibrosis Study Pro00115755. A Phase 3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects with Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis.
Clinical TrialPrincipal Investigator · Awarded by 89bio, Inc · 2024 - 2029Nonalcoholic Fatty Liver Disease (NAFLD) in Polycystic Ovary Syndrome: The Role of Androgens on Visceral Fat, Lipid Metabolites, and Liver Injury in Young Women
ResearchPrincipal Investigator · Awarded by University of California - San Francisco · 2023 - 2028View All Grants
Education, Training & Certifications
American University of the Caribbean ·
2005
M.D.